Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/1994
03/03/1994WO1994004702A2 Improved detection and therapy of lesions with biotin/avidin conjugates
03/03/1994WO1994004690A1 Bispecific immunoadhesins
03/03/1994WO1994004686A1 Tat-derived transport polypeptides
03/03/1994WO1994004685A1 Recombinant antigens and vaccines of bovine ephemeral fever virus
03/03/1994WO1994004683A1 Bordetella bronchiseptica vaccine
03/03/1994WO1994004680A1 Human interleukin-13
03/03/1994WO1994004678A1 Immunoglobulins devoid of light chains
03/03/1994WO1994004676A1 Stress protein epitopes
03/03/1994WO1994004662A1 Papillomavirus: biosynthetic process and assays
03/03/1994WO1994004661A1 Virus obtainable from human neuroblastoma cells
03/03/1994WO1994004565A2 Ipnv vaccine
03/03/1994WO1994004564A1 T cell epitopes of ryegrass pollen allergen
03/03/1994WO1994004557A1 Immunomodulatory peptides
03/03/1994WO1994004552A1 Opioid receptor genes
03/03/1994WO1994004301A1 Quick-change tool holder with center-height adjustment mechanism
03/03/1994WO1994004196A1 Tumour therapy
03/03/1994WO1994004195A1 Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
03/03/1994WO1994004188A1 Method for treating an lfa-1-mediated disorder
03/03/1994WO1994004187A1 Method for improving the growth and the quality of carcases of domestic meat-producer animals, vaccination kit et vaccines
03/03/1994WO1994004186A1 Homeopathic compositions for the treatment of viral and metabolic diseases
03/03/1994WO1994004185A2 Method of inhibiting reduction of disulfide bonds
03/03/1994WO1994004180A2 Novel uses of il-4 and/or il-10, and antibodies against the same
03/03/1994WO1994004174A1 Cytokine applications
03/03/1994WO1994004171A1 Immunomodulatory peptides
03/03/1994WO1994004121A1 Bystander suppression of retroviral-associated neurological disease
03/03/1994WO1993015205A3 Synthetic haemophilus influenzae conjugate vaccine
03/03/1994DE4228787A1 Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate New HIV-1 isolates of subtype vaccine against HIV-1 virus infection of this subtype and methods for their production, use of the HIV-1 virus isolates
03/03/1994CA2393847A1 Immunoglobulins devoid of light chains
03/03/1994CA2142902A1 Virus obtainable from human neuroblastoma cells
03/03/1994CA2142884A1 Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
03/03/1994CA2142881A1 Detection and therapy of lesions with biotin/avidin conjugates
03/03/1994CA2142872A1 Methods for monitoring effectiveness of interferon therapy in individuals with hcv infections
03/03/1994CA2142863A1 Homeopatic compositions for the treatment of viral and metabolic diseases
03/03/1994CA2142860A1 Human interleukin-13
03/03/1994CA2142469A1 Papillomavirus: biosynthetic process and assays
03/03/1994CA2142305A1 Opioid receptor genes
03/03/1994CA2141457A1 Cytokine applications
03/03/1994CA2140933A1 Method for treating an lfa-1 mediated disorder
03/03/1994CA2140280A1 Bispecific immunoadhesins
03/03/1994CA2104976A1 Separation of plasma or serum from whole blood using a red blood cell binding component and a polymer containing multiple cationic sites
03/02/1994EP0584767A1 Rapid extraction and neutralization of streptococcal antigen
03/02/1994EP0584715A2 Isolation and culturing of transformed cells and preparation of antibodies against them
03/02/1994EP0584552A2 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
03/02/1994EP0584421A1 Immunoglobulins devoid of light chains
03/02/1994EP0584348A1 Genetic vaccine for immunodeficiency viruses
03/02/1994EP0584284A1 Recombinant dna-derived cholera toxin subunit analogs
03/02/1994EP0584279A1 Targeted delivery of genes encoding immunogenic proteins
03/02/1994EP0584273A1 Antibody recognizing endothelial cell ligand for leukocyte cr3
03/02/1994EP0584266A1 Recombinant virus expressing carcinoembryonic antigen and methods of use thereof
03/02/1994EP0584251A1 Cytokine receptor targeted molecules for treatment of meoplastic cell growth
03/02/1994EP0584229A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND
03/02/1994EP0584212A1 Liposomal polysaccharide vaccines
03/02/1994EP0584201A1 Transmission-blocking vaccine against malaria
03/02/1994EP0584175A1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual
03/02/1994EP0584167A1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
03/02/1994EP0584136A1 Determination of motifs of peptides on mhc molecules
03/02/1994EP0584082A1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides
03/02/1994EP0470980B1 Synthetic peptides for an hiv-1 vaccine
03/02/1994EP0391896B1 Enhanced uptake drug delivery system
03/02/1994EP0371998B1 Modular assembly of antibody genes, antibodies prepared thereby and use
03/02/1994EP0347433B1 Recombinant antibody
03/02/1994EP0266419B1 Fibrinolytic composition
03/02/1994CN1082923A Process for attenuated varicella zoster virus vaccine production
03/01/1994US5290688 Preparation of exoantigens and vaccine for cattle
03/01/1994US5290681 Method of assaying immunization stimulating activity
03/01/1994US5290571 Undenatured whey protein providing Vitamins B1 and B2
03/01/1994US5290563 Method for combining a mixture of heterogeneous substances with liposomes
03/01/1994US5290551 Anticarcinogenic agents, immunology
03/01/1994US5290540 Administering, in small particle aerosol form, an anti-inflammatory agent of a corticosteroid, indomethacin, ibuprofen or acetylsalicylic acid and an anti-infectious agent
03/01/1994CA2104998A1 Bone-related carboxypeptidase-like protein and process for its production
03/01/1994CA2104997A1 Bone-related cadherin-like protein and process for its production
03/01/1994CA2104995A1 Bone-related sulfatase-like protein and process for its production
03/01/1994CA1327332C Animal derived cell with antigenic protein introduced therein
03/01/1994CA1327331C Vaccines
03/01/1994CA1327329C Recombinant diphtheria toxin fragments
03/01/1994CA1327313C Composition for controlling mastitis in ruminants, method for its preparation and method of treatment of ruminants
02/1994
02/27/1994CA2104244A1 Rapid extraction and neutralization of streptococcal antigen
02/23/1994EP0584023A1 Mycobacteria DNA fragments, amplification primers, hybridization probes, reagents and detection process of mycobacteria
02/23/1994EP0583998A1 Avirulent antirabies vaccine
02/23/1994EP0583799A1 Monoclonal antibodies to ELAM-1 sialoglycoprotein antigen on the surface of activated endothelial cells
02/23/1994EP0583794A1 Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects
02/23/1994EP0583356A1 A method for treating infectious respiratory diseases
02/23/1994CN1082606A Genetically engineered attenuated viruses
02/22/1994US5288854 Antiinflammatory agents
02/22/1994US5288845 Eimeria necatrix 16s rDNA probes
02/22/1994US5288639 Purified candidal stress protein or immunogenic epitope or homolog thereof
02/22/1994US5288630 For preparing specific immune responses against human respiratory syncytial virus
02/22/1994US5288617 Method of producing an antigenic preparation
02/22/1994US5288615 Methods for preparing proteins of altered structure
02/22/1994US5288607 Polypeptides having a β-adrenergic receptor activity in man, implicated in the lipolytic response, nucleic acids coding for these polypeptides and the use of these polypeptides for the screening of a substance active on these polypeptides
02/22/1994US5288502 Drug delivery
02/22/1994CA1327168C Anti-trichomonas vaginalis monoclonal antibodies
02/22/1994CA1327162C Method for prophylactically treating an individual for an autoimmune disease
02/17/1994WO1994003813A1 Immunoassay for detecting collagen or collagen fragments
02/17/1994WO1994003810A1 Method for detecting mycoplasmic infections
02/17/1994WO1994003644A1 Inhibitors of cell proliferation, their preparation and use
02/17/1994WO1994003628A1 Recombinant equine herpesviruses
02/17/1994WO1994003621A1 Vector vaccines of recombinant feline herpesvirus
02/17/1994WO1994003620A2 Method of increasing expression of viral proteins
02/17/1994WO1994003615A1 Expression of recombinant fusion proteins in attenuated bacteria